Palisades Hudson Asset Management, L.P. Gilead Sciences, Inc. Transaction History

Palisades Hudson Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $183,816 - $231,116	-2,960 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $185,384 - $237,451	2,960 New	2,960 $221,000
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $236,988 - $265,489	-3,790 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $273,296 - $323,931	3,790	3,790 $307,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Palisades Hudson Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Palisades Hudson Asset Management, L.P. with notifications on news.